LOS ANGELES, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 8, 2025.

Robinhood Markets' HOOD shares are trading at a massive premium to the industry. At present, the company has a price/tangible book (P/TB) of 14.69X for the trailing 12 months compared with the industry average of 2.93X.

FCPT adds two Hawaiian Bros sites in Arizona and Texas via a $5.9M sale-leaseback, extending its net-lease growth push.

Nano-X Imaging remains a 'sell' due to weak revenue growth, worsening losses, and limited traction in its core business. NNOX's advanced imaging technology and AI offerings have yet to translate into significant sales, with most revenue still from teleradiology services. Recent partnerships and acquisitions, including VasoHealthcare IT and European distribution deals, offer potential but lack a clear financial impact.

The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, 2025. Among the Fund's top-performing sectors in terms of adding value were Financials and Consumer Staples. From a factor perspective, the Fund's focus on profitable, liquid, and higher quality small cap stocks negatively impacted relative performance during the quarter.

LOS ANGELES, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. (“Molina” or “the Company”) (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 2, 2025.

Annaly Capital offers an attractive opportunity for income investors, driven by its high dividend yield and large Agency MBS portfolio. NLY stands to benefit from falling interest rates, which should boost agency MBS prices, book value, and support continued dividend payments. Current dividend coverage is strong at 104%, with a $0.70 quarterly payout and a yield just below 13%, making it appealing for yield-focused investors.

DGX's strong YTD gains and momentum in advanced diagnostics and acquisitions highlight why it may stand out in the competitive testing market against HOLX.

Airlines stocks have overcome severe turbulence in 2025 to fly into positive territory. But there's more trouble ahead and the sector needs a strong holiday travel period to hold on to its gains.

SKYW rides on strong demand, rising estimates and expanding E175 capacity, powering standout stock gains and operational momentum.

Ahead of Cyber Monday, picks highlight long-term cybersecurity potential as CRWD, QLYS and CYBR leverage rising demand for advanced protection.

AMZN, NVDA, PLTR and MU emerge as top large-cap tech picks as markets rebound and December rate cut hopes lift sentiment.

OKLO's volatile microreactor ambitions and D's steady nuclear backbone offer a stark contrast as both vie for a growing clean-power future.

Vistra remains a Hold as the stock's upside is balanced by significant risks and a valuation that already prices in strong execution. VST's strengths include a diversified power generation portfolio, recent acquisitions, and exposure to rising U.S. electricity demand, but operational setbacks and high debt add risk. Current valuation reflects optimism, leaving little room for error; any project missteps or regulatory changes could drive the stock lower.

Corporación América Airports has delivered strong Q3 2025 results, driven by passenger growth, higher unit revenues, and expanding EBITDA margins. CAAP's international and domestic traffic both grew, with notable strength in Argentina and Armenia, supporting robust revenue and margin expansion. I am revising my rating from strong buy to buy, reflecting lower EBITDA and free cash flow expectations for 2025-2026 and a slightly overvalued current multiple.

CRM's Q3 performance is anticipated to reflect the benefits of the increasing adoption of generative AI-enabled solutions and continued digital transformation.

Beam's broad early-stage pipeline and recent study progress take center stage as investors weigh its potential against rival NTLA's prospects.

The reason for my previous (skeptical) stance on FSCO was that I saw a clear case for FSCO's valuation converging closer to that of discounted BDC level. The thesis has worked out so far. Yet, given the Q3 details and FSCO's weak portfolio properties, I remain confident that there is still some decent downside left.

The long US stock market rally may be on the verge of a shift, with earnings growth finally starting to spread beyond the tech giants that have carried the S&P 500 for the past three years, according to Deutsche Bank's 2026 outlook. The bank thinks the index could hit 8,000 by the end of 2026, delivering mid-teens returns from here.

CleanSpark's faster growth, lower valuation and AI-HPC pivot give it an edge over Strategy in this Bitcoin-linked matchup.